CClinicalTrials.gg
CompletedNCT00443027HWO VBFUpdated May 28, 2019

Effect Of Menstrual Cycle On Vaginal Blood Flow In Pre-Menopausal Healthy Women.

A Phase 1 interventional study of Vaginal Heat Wash-Out Device in Sexual Dysfunction, Physiological, sponsored by Pfizer. Completed at 2 sites in Australia. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-05-28.

Sponsored by Pfizer · Phase 1, Interventional, and Other

Phase
Phase 1
Study type
Interventional
Enrollment
12
Allocation
Non-randomized
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

The Pfizer developed Heat Wash-Out (HWO) system is a software controlled electromechanical system designed to measure vaginal wall blood flow. A small vaginal probe is attached to a control unit. Output data is collected on a PC. By measuring the clearance of heat from the heated probe, a direct measure of absolute blood flow can be obtained. The study will assess changes in vaginal blood flow across the menstrual cycle following visual sexual stimulation.

Read the detailed description

Medical Device Development

02

Conditions studied

  • Sexual Dysfunction, Physiological
03

In context

Sexual Dysfunction, Physiological

115 studies on the registry are indexed under Sexual Dysfunction, Physiological; 46 are open to participants now.

This study's planned enrollment of 12 is below the median of 60 across 80 interventional studies indexed under Sexual Dysfunction, Physiological.

Browse Sexual Dysfunction, Physiological studies →

Lead sponsor

Pfizer is the lead sponsor of 3,244 studies on the registry; 139 are open to participants now.

Of its 582 completed or terminated interventional studies of FDA-regulated products, 381 (65%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Pre-menopausal healthy women aged 18-45 with regular, natural menstrual cycles.
  • Subjects must be void of Female Sexual Disorder.

Exclusion criteria

Exclusion Criteria:

  • Pregnant or lactating women
  • Postmenopausal subjects
  • Subjects with evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric or neurologic disease.
05

Study design

Phase
Phase 1
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
12 participants (estimated)

Study arms

  • Experimental
    Vaginal Heat Wash-Out Device

    Device: Vaginal Heat Wash-Out Device

Interventions

  • DeviceVaginal Heat Wash-Out Device

    No drug administered. Device tested three times with each subject.

06

What researchers measure

Primary outcomes

  1. To investigate differences in vaginal blood flow across the menstrual cycle following visual sexual stimulation.

    Time frame: 28d

  2. To assess the safety and toleration of the heat washout device.

    Time frame: 28d

Secondary outcomes

  1. To investigate changes in subjective acute sexual arousal following visual sexual stimulation across the menstrual cycle.

    Time frame: 28d

07

Study locations

2 sites
  • Pfizer Investigational Site
    Dulwich, South Australia 5065, Australia
  • Pfizer Investigational Site
    Nedlands, Western Australia 6009, Australia
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 28, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00443027
Lead sponsor
Pfizer
Responsible party
Sponsor
First posted
Mar 5, 2007
Start date
Mar 2007
Primary completion
Oct 2008
Completion
Oct 2008
Last update
May 28, 2019

Study contacts

Pfizer CT.gov Call Center
study director · Pfizer

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion